NYSE:OI
NYSE:OIPackaging

O-I Glass (OI) Is Up 6.8% After Wave Of Analyst Upgrades Highlights Profit-Improvement Potential

In early January 2026, O-I Glass drew renewed attention after multiple Wall Street firms upgraded their ratings, highlighting the company’s leading positions in glass container markets across Europe, North America, and Brazil. Analysts emphasized that O-I Glass’s potential for self-help driven profit improvement and resilience in a challenging packaging demand backdrop is reshaping how investors view the business. Next, we’ll examine how Wells Fargo’s upgrade to Overweight, alongside other...
NasdaqGM:DAVE
NasdaqGM:DAVEConsumer Finance

Dave (DAVE) Is Up 5.4% After Strong Buy Consensus and Record Q3 Revenue Growth - Has The Bull Case Changed?

Recently, digital banking platform Dave received a ‘Strong Buy’ consensus from seven analysts, following its previously reported record third-quarter revenue that was 63% higher than the same period a year earlier. This upbeat analyst view, combined with higher average revenue per user and growth in monthly transacting members, highlights how the market is reacting to Dave’s expanding customer engagement. Next, we’ll examine how this stronger analyst conviction, underpinned by record...
NYSE:DHI
NYSE:DHIConsumer Durables

Fresh Look At D.R. Horton (DHI) Valuation After Recent Share Price Weakness

Fresh look at D.R. Horton after recent share performance D.R. Horton (DHI) has drawn fresh investor attention after a period in which the stock slipped around 9% over both the past month and the past 3 months, inviting a closer look at its fundamentals. See our latest analysis for D.R. Horton. The recent 30 day share price return shows a decline of around 9%, and similar 90 day weakness contrasts with D.R. Horton’s 1 year total shareholder return of about 6%. This suggests momentum has faded...
NasdaqGS:TMUS
NasdaqGS:TMUSWireless Telecom

What T-Mobile US (TMUS)'s New Family Bundle and Debt Raise Strategy Means For Shareholders

T-Mobile US recently launched its Better Value family plan, offering premium 5G data, streaming perks, satellite connectivity and a five-year price guarantee from US$140 per month for three lines, while also expanding its revolving credit facility to US$10.00 billion and announcing a new fixed-rate senior notes offering. By pairing an aggressively priced, benefit-rich family bundle with greater funding flexibility, T-Mobile appears to be sharpening its push for higher-value multi-line...
NYSE:FIX
NYSE:FIXConstruction

Why Comfort Systems USA (FIX) Is Up 9.3% After Surging Data Center-Fueled Earnings Beat

In the past quarter, Comfort Systems USA reported same-store revenue growth of 33%, with margins improving, earnings per share more than doubling, and quarterly EBITDA surpassing US$400 million for the first time, driven largely by a 71% revenue increase in its electrical segment. Management highlighted that investments in technology, including automation, off-site fabrication and modular methods, are enabling the company to capture growing demand from data centers, advanced technology...
NasdaqGS:RXRX
NasdaqGS:RXRXBiotechs

Why Recursion Pharmaceuticals (RXRX) Is Up 10.7% After Positive REC-4881 Trial Data And Rising Analyst Focus

In late 2025, Recursion Pharmaceuticals reported strong Phase 1b/2 TUPELO trial data for its MEK 1/2 inhibitor REC-4881 in familial adenomatous polyposis, followed by management’s participation in major healthcare conferences and increased attention from Wall Street analysts. The combination of positive REC-4881 efficacy signals and growing institutional interest has sharpened focus on Recursion’s AI-enabled drug discovery model as a potential value driver. We’ll now examine how the...
NYSE:VLO
NYSE:VLOOil and Gas

Is It Too Late To Consider Valero Energy (VLO) After Its Strong Multi‑Year Rally?

If you are wondering whether Valero Energy is priced fairly after its strong run, this article will walk through what the current market price might be implying about the company. The stock recently closed at US$178.27, with returns of 8.1% over the last 7 days, 2.4% over 30 days, 7.8% year to date, 48.3% over 1 year and 48.1% over 3 years, and a very large 5 year return of 259.4%. These moves have kept Valero Energy on the radar for investors who follow large US refiners and energy names...
NasdaqGM:TNGX
NasdaqGM:TNGXBiotechs

Assessing Tango Therapeutics (TNGX) Valuation After Strong Share Price Momentum

Event context and recent stock performance Tango Therapeutics (TNGX) has been attracting fresh attention after a period of strong longer term share performance, with the stock showing a total return close to 179% over the past year. See our latest analysis for Tango Therapeutics. The recent 8.5% 1 day and 12.1% 7 day share price returns, alongside a 39.9% 90 day share price return, sit against a 178.7% 1 year total shareholder return. This suggests momentum has been building over time. If...
NYSE:BXP
NYSE:BXPOffice REITs

A Look At BXP (BXP) Valuation After Recent Share Price Move And Perceived Discount To Fair Value

Event context and why BXP is on investors’ radar BXP (BXP) is back in focus after its recent share move, with the stock last closing at $68.10, which is putting fresh attention on how its returns and fundamentals stack up today. See our latest analysis for BXP. BXP’s recent 1 day share price return of 1.51% comes after a softer patch, with the 90 day share price return of 6.75% decline contrasting with a 3 year total shareholder return of 20.12%. This suggests that longer term holders have...
NasdaqGS:LOPE
NasdaqGS:LOPEConsumer Services

Expanded Buyback And Nonprofit Win Could Be A Game Changer For Grand Canyon Education (LOPE)

In recent days, Grand Canyon Education increased its stock repurchase authorization by US$300 million to US$2.55 billion and Grand Canyon University secured formal recognition of its non-profit status from the U.S. Department of Education, resolving a longstanding dispute. This combination of an enlarged buyback pool and clarified non-profit status could reshape how investors assess the company’s capital allocation and growth avenues tied to scholarships, grants, and partnerships. Next,...
NasdaqGS:CDNS
NasdaqGS:CDNSSoftware

Cadence Design Systems (CDNS) Valuation After Chiplet Ecosystem Launch With Arm And Samsung Foundry

Cadence Design Systems (CDNS) has launched a Chiplet Spec-to-Packaged Parts ecosystem focused on physical AI, data center, and high performance computing, in partnership with Arm, Samsung Foundry, and several IP providers. See our latest analysis for Cadence Design Systems. The Chiplet Spec-to-Packaged Parts launch lands after a softer 90-day share price return of 10.10% and a 30-day share price return decline of 6.78%, while the 3-year total shareholder return of 91.48% and 5-year total...
NYSE:TRV
NYSE:TRVInsurance

Is Travelers Companies (TRV) Still Attractive After Its Strong Multi Year Share Price Run?

If you are wondering whether Travelers Companies at US$285.19 is still reasonably priced or starting to look expensive, you are in the right place to unpack what the current share price might be implying. The stock has had a mixed recent run, with a 2.5% decline over the last 7 days, a 1.5% return over 30 days, and a 19.9% return over the past year. The 3 year and 5 year returns sit at 57.9% and 124.6% respectively. Alongside these moves, investors have been reacting to ongoing sector wide...
NasdaqGS:PYPL
NasdaqGS:PYPLDiversified Financial

How Investors May Respond To PayPal (PYPL) Turning Its Transaction Graph Into a Marketing Insights Engine

Earlier this week, PayPal launched its Transaction Graph Insights & Measurement program, using data from over 430 million consumer accounts and tens of millions of merchants to give brands a cross-merchant view of real shopper behavior and advertising performance. The new suite positions PayPal as an insights provider as well as a payments platform, turning its transaction graph into a tool for merchants to identify high-intent shoppers and quantify true sales lift rather than modeled...
NasdaqGS:GRAB
NasdaqGS:GRABTransportation

3 Stocks Estimated To Be Up To 49.5% Below Intrinsic Value Offering Investment Potential

As the U.S. stock market experiences mixed movements, with major indices like the Dow Jones and S&P 500 setting fresh all-time highs, investors are navigating a landscape marked by geopolitical developments and fluctuating oil prices. In this environment, identifying undervalued stocks—those trading below their intrinsic value—can offer potential investment opportunities for those looking to capitalize on market inefficiencies amidst these dynamic conditions.
NasdaqGS:CLOV
NasdaqGS:CLOVHealthcare

Top Insider-Owned Growth Companies To Watch In January 2026

As the U.S. stock market experiences mixed movements with the Dow Jones and S&P 500 reaching fresh all-time highs, investors are keeping a close eye on geopolitical developments and economic indicators such as employment data. In this environment, growth companies with high insider ownership can be particularly appealing, as they often signal strong confidence from those who know the business best and may offer resilience amid market fluctuations.
NasdaqGM:TKNO
NasdaqGM:TKNOLife Sciences

3 Promising Penny Stocks With Market Caps Up To $300M

Major stock indexes in the United States have recently shown mixed performance, with the Dow Jones Industrial Average and S&P 500 setting fresh all-time highs. Amid these fluctuating market conditions, investors are increasingly exploring diverse opportunities to maximize potential returns. Penny stocks, though a term from earlier market days, continue to represent intriguing investment prospects by offering access to smaller or newer companies at lower price points. By identifying those with...
NYSE:HIPO
NYSE:HIPOInsurance

Discovering Hidden Opportunities in US Stocks

As the Dow Jones and S&P 500 reach new all-time highs, the U.S. stock market continues to capture investors' attention amidst mixed economic signals, including a weakening labor market and geopolitical developments. In this dynamic environment, identifying promising small-cap stocks can offer valuable opportunities for growth, particularly when these companies demonstrate resilience and potential in sectors poised for expansion.
NasdaqGM:CRSP
NasdaqGM:CRSPBiotechs

Is CRISPR Therapeutics (CRSP) Attractively Priced After Recent Gene Editing Progress?

If you are trying to work out whether CRISPR Therapeutics is priced attractively right now, it helps to first line up what the recent share moves and current valuation are really telling you. The stock last closed at US$58.19, with returns of 9.4% over the past week, 2.3% over the past month, 8.2% year to date, 38.8% over the past year and 20.6% over three years, while the five year return sits at a 69.4% decline. Recent attention on CRISPR Therapeutics has been shaped by news around its...
NYSE:GD
NYSE:GDAerospace & Defense

Reassessing General Dynamics (GD) Valuation After Strong Multi Year Returns And Backlog Support

General Dynamics (GD) has drawn fresh attention as investors reassess major defense and aerospace names, with the stock recently closing at $360.71 after a year that included double digit total returns. See our latest analysis for General Dynamics. The recent move in General Dynamics' share price, including a 6.9% 1 month share price return and a 5.0% year to date share price return, sits alongside a 41.8% 1 year total shareholder return and 162.8% 5 year total shareholder return. This points...
NYSE:CHWY
NYSE:CHWYSpecialty Retail

Will Chewy’s (CHWY) Earnings Beat and Viking’s Stake Increase Shift Its Profit Narrative?

In its most recent quarter, Chewy reported US$3.12 billion in revenue, an 8.3% year-on-year increase that modestly exceeded analyst expectations and was accompanied by stronger-than-expected EBITDA performance. Shortly after these results, Viking Global Investors lifted its Chewy stake by very large double digits, highlighting strong institutional conviction in the company’s underlying business strength despite earlier pressure on the shares. Next, we’ll examine how Viking Global’s larger...
NYSE:SSB
NYSE:SSBBanks

Assessing SouthState Bank (SSB) Valuation After Recent Share Price Momentum And Long Term Returns

SouthState Bank (SSB) shares have been drawing attention after recent trading, with the stock last closing at $97.12. Investors are weighing this price against the bank’s earnings profile and overall return history. See our latest analysis for SouthState Bank. The recent 1-day share price return of 1.64% and 1-month share price return of 5.40% suggest some momentum is building, even though the 3.07% year to date share price return and 3.57% 1-year total shareholder return remain relatively...
NYSE:DOLE
NYSE:DOLEFood

Assessing Dole (DOLE) Valuation After Mixed Short Term Weakness And Stronger Multi Year Returns

Dole (NYSE:DOLE) has recently drawn attention after a mixed run in the stock, with a decline over the past month but a gain over the past 3 months. This has prompted closer scrutiny of its current valuation. See our latest analysis for Dole. Over the past year, Dole’s share price has had a softer year to date but a stronger 90 day run, while its 1 year and 3 year total shareholder returns point to more supportive longer term momentum. If Dole’s recent moves have you rethinking your watchlist,...
NasdaqGS:MEDP
NasdaqGS:MEDPLife Sciences

Is Medpace (MEDP) Using Its 52-Week High Consolidation to Redefine Its Clinical CRO Edge?

In recent months, Medpace Holdings has been consolidating near its 52-week high after a strong multi-month rally, while announcing that it will report its fourth quarter and fiscal year 2025 results on 9 February 2026, followed by a conference call on 10 February 2026. This period has highlighted continued optimism around Medpace’s leadership in complex outsourced clinical research and disciplined margin management, reinforced by generally constructive analyst views despite some valuation...
NasdaqCM:DCTH
NasdaqCM:DCTHMedical Equipment

A Look At Delcath Systems (DCTH) Valuation After New Phase 3 FOCUS Subgroup Data On HEPZATO KIT

Delcath Systems (DCTH) is back in focus after publishing detailed subgroup analyses from its phase 3 FOCUS study on HEPZATO KIT in unresectable metastatic uveal melanoma, helping refine how clinicians view efficacy and safety across different patient groups. See our latest analysis for Delcath Systems. The publication arrives after a mixed stretch for Delcath Systems, with a 30 day share price return of 6.85% and a 90 day share price return decline of 5.86%. The 3 year total shareholder...